The perils of partnering for profit
Editor’s note: The opinions expressed in the following blog post are the author’s own and do not reflect the views
Read moreEditor’s note: The opinions expressed in the following blog post are the author’s own and do not reflect the views
Read moreFrancis Collins, NIH Director, and Scott Gottlieb, FDA Commissioner, recently announced plans to eliminate oversight of new gene therapy experiments
Read moreBy now, you may have read stories about a gene editing technique called CRISPR/Cas9. CRISPR is poised to revolutionize the
Read moreA few weeks ago, my colleague Stephanie Morain wrote a PolicyWise post on attempts to pass so-called “right-to-try” legislation in
Read moreIn her critically acclaimed one-person show, Let Me Down Easy, Anna Deavere Smith re-enacts interviews with people observing the rich
Read moreOn April 1, 2016, the European Medicines Agency (EMA) approved the first ex-vivo (outside the body) gene therapy in the
Read more